Johnson & Johnson (JNJ) Tops Q4 EPS by 11c, Revenues Misses; Guides EPS Above Views
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $260.86 --0%
Financial Fact:
Provision for taxes on income (Note 5): 1.01B
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Provision for taxes on income (Note 5): 1.01B
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.35, $0.11 better than the analyst estimate of $2.24. Revenue for the quarter came in at $23.7 billion versus the consensus estimate of $23.9 billion.
GUIDANCE:
Johnson & Johnson sees FY2023 EPS of $10.50, versus the consensus of $10.33.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
- Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
